To The Moon

First month trading whole day, operating mostly after hours and before the market opens, over 10% profit, aiming to triple that and become a pro by end of the year

$Eledon Pharmaceuticals, Inc.(ELDN)$  50% gain

$NIO Inc.(NIO)$  neat 30% up

$Etsy(ETSY)$  taking advantage of the post-earnings debacle bounce

Well perhaps if they hadn´t pushed expats out and increased stamp duties to 60% among other things, Singapore would remain attractive as a place to place your money.

I don´t see Meta going anywhere, if the metaverse evolves to something similar as seen in Ready Player Number One it will be through Google, Microsoft or Sony. On the other hand Snap approach as a VR makes much more sense but still I wouldn´t bet on them to be the most profitable for extensive VR applications/impementations

$Invitae(NVTA)$¿End of Invitae's uptrend for now?

$Sphere 3D(ANY)$playing safe

$Digital Brands Group, Inc.(DBGI)$diamond hands here, this company is gonna keep growing through Amazon. Holding it till 2022 and maybe beyond!

Great frist results from $CRISPR Therapeutics AG(CRSP)$& $Vertex(VTNR)$study on gen editing therapy to cure Thalssemia.CRSP is a clear win for 5y+ investors and has a massive growth ahead for the next 10 years, as a Biologist I can't but agree on the 9X figures.“This approach uses CRISPR/Cas9 gene editing to enable the patient’s own cells to produce fetal hemoglobin, and to see results that demonstrate the potential for a treatment that may transform the lives of many patients is an exciting time for me and the team.”https://www.businesswire.com/news/home/20210611005069/en/Vertex-and-CRISPR-Therapeutics-Present-New-Data-in-22-Patients-With-Greater-Than-3-Months-Follow-Up-Post-Treatment-With-Invest